Calumet Specialty Products Partners (NASDAQ:CLMT) Stock Price Up 3.7% - Here's Why

Shares of Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT - Get Free Report) were up 3.7% during trading on Wednesday . The company traded as high as $12.60 and last traded at $12.69. Approximately 73,200 shares were traded during trading, a decline of 90% from the average daily volume of 700,350 shares. The stock had previously closed at $12.23.Wall Street Analyst Weigh In2 Energy Stocks Surging on Billion-Dollar DOE Loan CommitmentsSeveral research analysts have recently issued reports on CLMT shares. TD Cowen cut shares of Calumet Specialty Products Partners from a "buy" rating to a "hold" rating and decreased their price objective for the company from $26.00 to $16.00 in a report on Tuesday, March 4th. Wells Fargo & Company cut their target price on Calumet Specialty Products Partners from $29.00 to $28.00 and set an "overweight" rating for the company in a research report on Wednesday, March 5th. UBS Group upgraded Calumet Specialty Products Partners from a "sell" rating to a "neutral" rating and lowered their price target for the company from $15.00 to $12.00 in a research report on Monday, March 17th. Finally, HC Wainwright restated a "buy" rating and issued a $33.00 price objective on shares of Calumet Specialty Products Partners in a report on Monday, March 3rd. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $20.80.Read Our Latest Analysis on Calumet Specialty Products PartnersCalumet Specialty Products Partners Price PerformanceThe stock has a market capitalization of $1.07 billion, a P/E ratio of -4.57 and a beta of 1.88. The stock's fifty day moving average is $15.05 and its two-hundred day moving average is $18.55. Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last released its quarterly earnings data on Friday, February 28th. The oil and gas company reported ($0.47) earnings per share for the quarter, topping the consensus estimate of ($1.06) by $0.59. The company had revenue of $949.50 million for the quarter, compared to the consensus estimate of $921.76 million. The business's revenue was down 2.8% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.59) earnings per share. Analysts expect that Calumet Specialty Products Partners, L.P. will post -3.02 EPS for the current year. Insider Buying and SellingIn other news, CFO David Lunin purchased 2,500 shares of Calumet Specialty Products Partners stock in a transaction that occurred on Tuesday, March 4th. The stock was acquired at an average price of $13.05 per share, for a total transaction of $32,625.00. Following the transaction, the chief financial officer now owns 2,500 shares in the company, valued at $32,625. The trade was a ∞ increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available at this link. 2.91% of the stock is currently owned by company insiders. Calumet Specialty Products Partners Company Profile (Get Free Report)Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.See AlsoFive stocks we like better than Calumet Specialty Products PartnersShould You Invest in Penny Stocks?Energy Transfer: Powering Data With Dividends and Diversification3 Stocks to Consider Buying in OctoberQualcomm Stock Is Coiling for a Breakout Basic Materials Stocks InvestingIs Alphabet Too Cheap to Ignore After Its Recent Correction?This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Calumet Specialty Products Partners Right Now?Before you consider Calumet Specialty Products Partners, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet Specialty Products Partners wasn't on the list.While Calumet Specialty Products Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here